Advances in Nanocarriers for Biofilm-Associated Infections

Advances in Nanocarriers for Biofilm-Associated Infections: From Research to Clinical Practice addresses the critical challenge of treating biofilm-associated infections, which are resistant to conventional antibiotics due to their protective microbial communities. This reference compiles cutting-edge research on nanocarriers, including nanoparticles, liposomes, dendrimers, and polymeric micelles, emphasizing their design and application to penetrate biofilms and enhance antimicrobial delivery. The comprehensive content covers biofilm formation, resistance mechanisms, and multidrug resistance, followed by detailed chapters on nanocarrier synthesis, functionalization, and therapeutic efficacy. Clinical and translational aspects are examined through case studies on chronic wounds, medical device infections, and respiratory biofilms, alongside regulatory hurdles and future research directions. The book features contributions from international experts, providing a multidisciplinary perspective on nanotechnology’s role in infection control.

It equips researchers, clinicians, and pharmaceutical professionals to understand complex biofilm biology, apply novel drug delivery systems, and navigate clinical challenges, ultimately supporting the development of improved treatments for persistent biofilm-related infections.

• Explores nanocarrier technologies targeting biofilm-associated infections
• Bridges research and clinical applications of nanocarriers in infection control
• Highlights strategies to overcome antibiotic resistance using nanotechnology
• Discusses regulatory and translational challenges in nanocarrier therapies
• Presents future perspectives and innovative approaches in biofilm treatment